LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy

Detalles Bibliográficos
Autores principales: Amati, Francesca, Diano, Laura, Vecchione, Lucia, Norata, Giuseppe Danilo, Koyama, Yoshikazu, Cutuli, Lucia, Catapano, Alberico Luigi, Romeo, Francesco, Ando, Hironori, Novelli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528301/
https://www.ncbi.nlm.nih.gov/pubmed/23212297
http://dx.doi.org/10.1038/mtna.2012.45
_version_ 1782253812599226368
author Amati, Francesca
Diano, Laura
Vecchione, Lucia
Norata, Giuseppe Danilo
Koyama, Yoshikazu
Cutuli, Lucia
Catapano, Alberico Luigi
Romeo, Francesco
Ando, Hironori
Novelli, Giuseppe
author_facet Amati, Francesca
Diano, Laura
Vecchione, Lucia
Norata, Giuseppe Danilo
Koyama, Yoshikazu
Cutuli, Lucia
Catapano, Alberico Luigi
Romeo, Francesco
Ando, Hironori
Novelli, Giuseppe
author_sort Amati, Francesca
collection PubMed
description
format Online
Article
Text
id pubmed-3528301
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-35283012012-12-22 LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy Amati, Francesca Diano, Laura Vecchione, Lucia Norata, Giuseppe Danilo Koyama, Yoshikazu Cutuli, Lucia Catapano, Alberico Luigi Romeo, Francesco Ando, Hironori Novelli, Giuseppe Mol Ther Nucleic Acids Letter to the Editor Nature Publishing Group 2012-12 2012-12-04 /pmc/articles/PMC3528301/ /pubmed/23212297 http://dx.doi.org/10.1038/mtna.2012.45 Text en Copyright © 2012 American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by-nc-nd/3.0/ Molecular Therapy-Nucleic Acids is an open-access journal published by Nature Publishing Group. This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Letter to the Editor
Amati, Francesca
Diano, Laura
Vecchione, Lucia
Norata, Giuseppe Danilo
Koyama, Yoshikazu
Cutuli, Lucia
Catapano, Alberico Luigi
Romeo, Francesco
Ando, Hironori
Novelli, Giuseppe
LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
title LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
title_full LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
title_fullStr LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
title_full_unstemmed LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
title_short LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
title_sort lox-1 inhibition in apoe ko mice using a schizophyllan-based antisense oligonucleotide therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528301/
https://www.ncbi.nlm.nih.gov/pubmed/23212297
http://dx.doi.org/10.1038/mtna.2012.45
work_keys_str_mv AT amatifrancesca lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT dianolaura lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT vecchionelucia lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT noratagiuseppedanilo lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT koyamayoshikazu lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT cutulilucia lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT catapanoalbericoluigi lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT romeofrancesco lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT andohironori lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy
AT novelligiuseppe lox1inhibitioninapoekomiceusingaschizophyllanbasedantisenseoligonucleotidetherapy

Ejemplares similares